• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血肌酐清除率降低与痛风患者皮下痛风石的早期发生有关。

Reduced creatinine clearance is associated with early development of subcutaneous tophi in people with gout.

机构信息

Bone and Joint Research Group, Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, 85 Park Rd, Grafton, New Zealand.

出版信息

BMC Musculoskelet Disord. 2013 Dec 21;14:363. doi: 10.1186/1471-2474-14-363.

DOI:10.1186/1471-2474-14-363
PMID:24359261
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3878111/
Abstract

BACKGROUND

Although typically a late feature of gout, tophi may present early in the course of disease. The aim of this study was to identify factors associated with the presence of early tophaceous disease.

METHODS

People with gout for <10 years were prospectively recruited, and had a comprehensive clinical assessment including examination for subcutaneous tophi. The clinical factors independently associated with the presence and number of tophi were analyzed using regression models.

RESULTS

Of the 290 participants, there were 47 (16.2%) with clinically apparent tophi. In univariate analysis, those with tophi were older, were more frequently taking diuretics and colchicine prophylaxis, and had lower creatinine clearance. The association between the presence of tophi and creatinine clearance was strongest in those with creatinine clearance ≤30 ml/min. In logistic regression analysis, creatinine clearance ≤30 ml/min was associated with the presence of tophi, even after adjusting for ethnicity, corticosteroid use, colchicine use and diuretic use (multivariate adjusted odds ratio 7.0, p = 0.005). Participants with tophi reported higher frequency of gout flares, pain scores, patient global assessment scores, and HAQ scores.

CONCLUSIONS

The presence of tophi is associated with more symptomatic disease in people with gout for <10 years. Creatinine clearance is independently associated with early presentation of subcutaneous tophi.

摘要

背景

尽管痛风石通常是痛风的晚期特征,但也可能在疾病早期出现。本研究旨在确定与早期痛风石病相关的因素。

方法

前瞻性招募了病程<10 年的痛风患者,并进行了全面的临床评估,包括皮下痛风石检查。使用回归模型分析与痛风石存在和数量相关的临床因素。

结果

在 290 名参与者中,有 47 名(16.2%)存在明显的皮下痛风石。在单因素分析中,有痛风石的患者年龄更大,更频繁地服用利尿剂和秋水仙碱预防药物,且肌酐清除率更低。在肌酐清除率≤30ml/min 的患者中,痛风石的存在与肌酐清除率之间的相关性最强。在逻辑回归分析中,即使在调整了种族、皮质类固醇使用、秋水仙碱使用和利尿剂使用后,肌酐清除率≤30ml/min 与痛风石的存在仍相关(多变量调整后的优势比为 7.0,p=0.005)。有痛风石的患者报告痛风发作频率更高、疼痛评分、患者整体评估评分和 HAQ 评分更高。

结论

在病程<10 年的痛风患者中,痛风石的存在与更严重的症状性疾病相关。肌酐清除率与皮下痛风石的早期出现独立相关。

相似文献

1
Reduced creatinine clearance is associated with early development of subcutaneous tophi in people with gout.血肌酐清除率降低与痛风患者皮下痛风石的早期发生有关。
BMC Musculoskelet Disord. 2013 Dec 21;14:363. doi: 10.1186/1471-2474-14-363.
2
Risk factors of ultrasound-detected tophi in patients with gout.痛风患者超声下尿酸盐结晶的危险因素。
Clin Rheumatol. 2020 Jun;39(6):1953-1960. doi: 10.1007/s10067-020-04947-2. Epub 2020 Feb 15.
3
Risk factors for ulceration over tophi in patients with gout.痛风患者痛风石溃疡形成的危险因素。
Int Wound J. 2017 Aug;14(4):704-707. doi: 10.1111/iwj.12680. Epub 2016 Oct 10.
4
Finger pad tophi in gout.痛风中的指腹痛风石
J Rheumatol. 1996 Apr;23(4):690-2.
5
Predictors of Mortality in People with Recent-onset Gout: A Prospective Observational Study.近期痛风患者死亡率的预测因素:一项前瞻性观察研究。
J Rheumatol. 2017 Mar;44(3):368-373. doi: 10.3899/jrheum.160596. Epub 2016 Dec 15.
6
Relationship between urate within tophus and bone erosion according to the anatomic location of urate deposition in gout: A quantitative analysis using dual-energy CT volume measurements.根据痛风中尿酸盐沉积的解剖位置,痛风石内尿酸盐与骨侵蚀之间的关系:使用双能CT体积测量的定量分析
Medicine (Baltimore). 2019 Dec;98(51):e18431. doi: 10.1097/MD.0000000000018431.
7
Clinically-evident tophi are associated with reduced muscle force in the foot and ankle in people with gout: a cross-sectional study.一项横断面研究:痛风患者中临床上明显的痛风石与足踝部肌肉力量减弱有关。
J Foot Ankle Res. 2017 Jun 19;10:25. doi: 10.1186/s13047-017-0207-4. eCollection 2017.
8
Clinical characteristics associated with subcutaneous tophi formation in Chinese gout patients: a retrospective study.与中国痛风患者皮下痛风石形成相关的临床特征:一项回顾性研究。
Clin Rheumatol. 2018 May;37(5):1359-1365. doi: 10.1007/s10067-017-3969-y. Epub 2018 Jan 22.
9
Characterization of patients with chronic refractory gout who do and do not have clinically apparent tophi and their response to pegloticase.有和没有临床可见痛风石的慢性难治性痛风患者的特征及其对聚乙二醇化尿酸酶的反应
Rheumatology (Oxford). 2019 Mar 6. doi: 10.1093/rheumatology/kez017.
10
Intradermal tophi in gout: a case-control study.痛风中的皮内痛风石:一项病例对照研究。
J Rheumatol. 1999 Jan;26(1):136-40.

引用本文的文献

1
The pathogenesis of gout.痛风的发病机制。
J Rheum Dis. 2025 Jan 1;32(1):8-16. doi: 10.4078/jrd.2024.0054. Epub 2024 Nov 6.
2
Gout comorbidities: results from the Korean National Health and Nutrition Examination Survey.痛风合并症:来自韩国国家健康和营养检查调查的结果。
Adv Rheumatol. 2024 Sep 27;64(1):76. doi: 10.1186/s42358-024-00413-8.
3
Gout Affecting the Nail Unit: Report of Two Cases and Literature Review.累及甲单位的痛风:2例报告及文献复习
Skin Appendage Disord. 2024 Apr;10(2):99-103. doi: 10.1159/000534668. Epub 2023 Nov 21.
4
Associated Factors of Tophaceous Gout: A Study Involving 20 Primary Care Clinics in an Urbanized State in Malaysia.痛风石性痛风的相关因素:一项涉及马来西亚一个城市化州20家基层医疗诊所的研究。
Oman Med J. 2023 Jul 31;38(4):e528. doi: 10.5001/omj.2023.87. eCollection 2023 Jul.
5
Population pharmacokinetics, pharmacodynamics and pharmacogenetics modelling of oxypurinol in Hmong adults with gout and/or hyperuricemia.黄嘌呤醇在患有痛风和/或高尿酸血症的苗族成年人中的群体药代动力学、药效学和药物遗传学建模。
Br J Clin Pharmacol. 2023 Oct;89(10):2964-2976. doi: 10.1111/bcp.15792. Epub 2023 Jun 4.
6
The Hong Kong Society of Rheumatology consensus recommendations for the management of gout.香港风湿病学会痛风管理共识建议。
Clin Rheumatol. 2023 Aug;42(8):2013-2027. doi: 10.1007/s10067-023-06578-9. Epub 2023 Apr 4.
7
Febuxostat Therapy for Patients with Gout and Stage 2-4 CKD: a Retrospective Study.非布司他治疗痛风和2-4期慢性肾脏病患者:一项回顾性研究。
Rheumatol Ther. 2022 Oct;9(5):1421-1434. doi: 10.1007/s40744-022-00480-7. Epub 2022 Sep 3.
8
Mini Review: Reappraisal of Uric Acid in Chronic Kidney Disease.综述:慢性肾脏病中尿酸的再评估。
Am J Nephrol. 2021;52(10-11):837-844. doi: 10.1159/000519491. Epub 2021 Oct 21.
9
Management of gout in chronic kidney disease: a G-CAN Consensus Statement on the research priorities.慢性肾脏病相关痛风管理:G-CAN 共识声明中关于研究重点的内容
Nat Rev Rheumatol. 2021 Oct;17(10):633-641. doi: 10.1038/s41584-021-00657-4. Epub 2021 Jul 30.
10
Prevalence of Musculoskeletal Manifestations in Adult Kidney Transplant's Recipients: A Systematic Review.成人肾移植受者肌肉骨骼表现的患病率:系统评价。
Medicina (Kaunas). 2021 May 23;57(6):525. doi: 10.3390/medicina57060525.

本文引用的文献

1
Primary care providers' knowledge, beliefs and treatment practices for gout: results of a physician questionnaire.初级保健提供者对痛风的知识、信念和治疗实践:医生问卷的结果。
Rheumatology (Oxford). 2013 Sep;52(9):1623-9. doi: 10.1093/rheumatology/ket158. Epub 2013 Apr 25.
2
Tophaceous gout and high level of hyperuricaemia are both associated with increased risk of mortality in patients with gout.痛风石和高尿酸血症均与痛风患者的死亡率增加相关。
Ann Rheum Dis. 2014 Jan;73(1):177-82. doi: 10.1136/annrheumdis-2012-202421. Epub 2013 Jan 12.
3
2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia.2012年美国风湿病学会痛风管理指南。第1部分:高尿酸血症的系统性非药物和药物治疗方法。
Arthritis Care Res (Hoboken). 2012 Oct;64(10):1431-46. doi: 10.1002/acr.21772.
4
Tophi and frequent gout flares are associated with impairments to quality of life, productivity, and increased healthcare resource use: Results from a cross-sectional survey.痛风石和频繁的痛风发作与生活质量受损、生产力下降以及增加医疗资源的使用有关:来自一项横断面调查的结果。
Health Qual Life Outcomes. 2012 Sep 22;10:117. doi: 10.1186/1477-7525-10-117.
5
Illness perceptions in patients with gout and the relationship with progression of musculoskeletal disability.痛风患者的疾病认知与肌肉骨骼残疾进展的关系。
Arthritis Care Res (Hoboken). 2011 Nov;63(11):1605-12. doi: 10.1002/acr.20570.
6
Does prolonged systemic glucocorticoid use increase risk of tophus formation among gouty arthritis patients?长期全身性糖皮质激素的使用是否会增加痛风关节炎患者痛风石形成的风险?
Int J Rheum Dis. 2009 Sep;12(3):243-9. doi: 10.1111/j.1756-185X.2009.01418.x.
7
Cellular characterization of the gouty tophus: a quantitative analysis.痛风石的细胞特征:定量分析
Arthritis Rheum. 2010 May;62(5):1549-56. doi: 10.1002/art.27356.
8
Progress in measurement instruments for acute and chronic gout studies.急性和慢性痛风研究中测量仪器的进展。
J Rheumatol. 2009 Oct;36(10):2346-55. doi: 10.3899/jrheum.090371.
9
Dual energy computed tomography in tophaceous gout.双能计算机断层扫描在痛风石性痛风中的应用
Ann Rheum Dis. 2009 Oct;68(10):1609-12. doi: 10.1136/ard.2008.099713. Epub 2008 Dec 9.
10
Mechanisms of bone erosion in gout: a quantitative analysis using plain radiography and computed tomography.痛风性骨侵蚀的机制:一项使用X线平片和计算机断层扫描的定量分析
Ann Rheum Dis. 2009 Aug;68(8):1290-5. doi: 10.1136/ard.2008.094201. Epub 2008 Aug 15.